{"id":"https://openalex.org/W4402200720","doi":"https://doi.org/10.1158/1078-0432.c.7429474","title":"Data from Safety, Efficacy, and Biological Data of T-Cell\u2013Enabling Oncolytic Adenovirus TILT-123 in Advanced Solid Cancers from the TUNIMO Monotherapy Phase I Trial","display_name":"Data from Safety, Efficacy, and Biological Data of T-Cell\u2013Enabling Oncolytic Adenovirus TILT-123 in Advanced Solid Cancers from the TUNIMO Monotherapy Phase I Trial","publication_year":2024,"publication_date":"2024-09-03","ids":{"openalex":"https://openalex.org/W4402200720","doi":"https://doi.org/10.1158/1078-0432.c.7429474"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.c.7429474","doi":"https://doi.org/10.1158/1078-0432.c.7429474","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.7429474","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1078-0432.c.7429474","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5009672863","display_name":"Santeri Artturi Pakola","orcid":"https://orcid.org/0000-0001-6235-8612","observed_orcids":["https://orcid.org/0000-0001-6235-8612"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Santeri A. Pakola","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-6235-8612","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011563007","display_name":"Katriina Johanna Peltola","orcid":"https://orcid.org/0000-0002-3007-193X","observed_orcids":["https://orcid.org/0000-0002-3007-193X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Katriina J. Peltola","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-3007-193X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036205283","display_name":"James H.A. Clubb","orcid":"https://orcid.org/0000-0002-9146-4817","observed_orcids":["https://orcid.org/0000-0002-9146-4817"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"James H.A. Clubb","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9146-4817","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022473081","display_name":"Elise Jirovec","orcid":"https://orcid.org/0009-0004-0606-6577","observed_orcids":["https://orcid.org/0009-0004-0606-6577"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Elise Jirovec","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0004-0606-6577","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052034162","display_name":"Lyna Haybout","orcid":"https://orcid.org/0009-0005-5170-5611","observed_orcids":["https://orcid.org/0009-0005-5170-5611"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lyna Haybout","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0005-5170-5611","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027603010","display_name":"Tatiana Viktorovna Kudling","orcid":"https://orcid.org/0000-0003-4481-1617","observed_orcids":["https://orcid.org/0000-0003-4481-1617"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tatiana V. Kudling","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-4481-1617","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065474301","display_name":"Tuomo Alanko","orcid":"https://orcid.org/0000-0002-1649-9040","observed_orcids":["https://orcid.org/0000-0002-1649-9040"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tuomo Alanko","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1649-9040","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007169190","display_name":"Riitta Korpisaari","orcid":"https://orcid.org/0009-0000-9924-1629","observed_orcids":["https://orcid.org/0009-0000-9924-1629"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Riitta Korpisaari","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0000-9924-1629","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019145336","display_name":"Susanna Juteau","orcid":"https://orcid.org/0000-0001-9321-2093","observed_orcids":["https://orcid.org/0000-0001-9321-2093"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Susanna Juteau","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9321-2093","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111313363","display_name":"Marjut Jaakkola","orcid":"https://orcid.org/0000-0003-1709-3138","observed_orcids":["https://orcid.org/0000-0003-1709-3138"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marjut Jaakkola","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-1709-3138","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024539974","display_name":"Jorma Sormunen","orcid":"https://orcid.org/0000-0002-1992-1251","observed_orcids":["https://orcid.org/0000-0002-1992-1251"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jorma Sormunen","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-1992-1251","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026147553","display_name":"Jukka Kemppainen","orcid":"https://orcid.org/0000-0001-9390-1198","observed_orcids":["https://orcid.org/0000-0001-9390-1198"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jukka Kemppainen","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9390-1198","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069463210","display_name":"Annabrita Hemmes","orcid":"https://orcid.org/0009-0005-5051-9331","observed_orcids":["https://orcid.org/0009-0005-5051-9331"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Annabrita Hemmes","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0005-5051-9331","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031007847","display_name":"Teijo S. Pellinen","orcid":"https://orcid.org/0000-0001-9652-7373","observed_orcids":["https://orcid.org/0000-0001-9652-7373"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Teijo Pellinen","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9652-7373","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102737024","display_name":"Mirte van der Heijden","orcid":"https://orcid.org/0009-0000-4123-6464","observed_orcids":["https://orcid.org/0009-0000-4123-6464"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mirte van der Heijden","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0000-4123-6464","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054296634","display_name":"Dafne C.A. Quixabeira","orcid":"https://orcid.org/0000-0003-2614-3942","observed_orcids":["https://orcid.org/0000-0003-2614-3942"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dafne C.A. Quixabeira","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-2614-3942","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047301856","display_name":"Claudia Kistler","orcid":"https://orcid.org/0009-0003-8445-4164","observed_orcids":["https://orcid.org/0009-0003-8445-4164"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Claudia Kistler","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0003-8445-4164","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062608835","display_name":"Suvi Sorsa","orcid":"https://orcid.org/0009-0002-1709-611X","observed_orcids":["https://orcid.org/0009-0002-1709-611X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Suvi Sorsa","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0002-1709-611X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029723342","display_name":"Riikka Havunen","orcid":"https://orcid.org/0009-0008-7926-5285","observed_orcids":["https://orcid.org/0009-0008-7926-5285"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Riikka Havunen","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0008-7926-5285","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072358689","display_name":"Jo\u00e3o Manuel Santos","orcid":"https://orcid.org/0000-0003-4639-1644","observed_orcids":["https://orcid.org/0000-0003-4639-1644"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Joao M. Santos","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-4639-1644","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080358452","display_name":"V\u00edctor Cervera-Carrasc\u00f3n","orcid":"https://orcid.org/0000-0001-6684-3666","observed_orcids":["https://orcid.org/0000-0001-6684-3666"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Victor Cervera-Carrascon","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-6684-3666","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5062078543","display_name":"Akseli Hemminki","orcid":"https://orcid.org/0000-0001-7103-8530","observed_orcids":["https://orcid.org/0000-0001-7103-8530"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Akseli Hemminki","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-7103-8530","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.001500000013038516,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/oncolytic-adenovirus","display_name":"oncolytic adenovirus","score":0.9959999918937683},{"id":"https://openalex.org/keywords/tnf-alpha","display_name":"TNF-\u03b1","score":0.6859999895095825},{"id":"https://openalex.org/keywords/interleukin-2","display_name":"interleukin-2","score":0.9679999947547913},{"id":"https://openalex.org/keywords/t-cell-infiltration","display_name":"T cell infiltration","score":0.8450000286102295},{"id":"https://openalex.org/keywords/advanced-solid-tumors","display_name":"advanced solid tumors","score":0.8299999833106995},{"id":"https://openalex.org/keywords/sarcoma","display_name":"sarcoma","score":0.753000020980835},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.9940000176429749},{"id":"https://openalex.org/keywords/ovarian-cancer","display_name":"ovarian cancer","score":0.9929999709129333},{"id":"https://openalex.org/keywords/intratumoral-injection","display_name":"intratumoral injection","score":0.7590000033378601},{"id":"https://openalex.org/keywords/intravenous-administration","display_name":"intravenous administration","score":0.8289999961853027},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7360000014305115},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.7760000228881836},{"id":"https://openalex.org/keywords/tumor-response","display_name":"tumor response","score":0.5080000162124634},{"id":"https://openalex.org/keywords/safety","display_name":"safety","score":0.41600000858306885},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.6930000185966492},{"id":"https://openalex.org/keywords/lymphocyte-trafficking","display_name":"lymphocyte migration","score":0.7070000171661377}],"concepts":[{"id":"https://openalex.org/C82210918","wikidata":"https://www.wikidata.org/wiki/Q1560099","display_name":"Oncolytic virus","level":3,"score":0.8548678159713745},{"id":"https://openalex.org/C2779844322","wikidata":"https://www.wikidata.org/wiki/Q2919140","display_name":"Tilt (camera)","level":2,"score":0.4758205711841583},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.47508302330970764},{"id":"https://openalex.org/C44280652","wikidata":"https://www.wikidata.org/wiki/Q104837","display_name":"Phase (matter)","level":2,"score":0.456545352935791},{"id":"https://openalex.org/C2777283488","wikidata":"https://www.wikidata.org/wiki/Q7095181","display_name":"Oncolytic adenovirus","level":4,"score":0.4452371895313263},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.41157758235931396},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3941369652748108},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3894655704498291},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.3346966803073883},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3258424997329712},{"id":"https://openalex.org/C3020616263","wikidata":"https://www.wikidata.org/wiki/Q1216998","display_name":"Tumor cells","level":2,"score":0.24443435668945312},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.1628449559211731},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.12960374355316162},{"id":"https://openalex.org/C78519656","wikidata":"https://www.wikidata.org/wiki/Q101333","display_name":"Mechanical engineering","level":1,"score":0.0},{"id":"https://openalex.org/C62520636","wikidata":"https://www.wikidata.org/wiki/Q944","display_name":"Quantum mechanics","level":1,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/1078-0432.c.7429474","doi":"https://doi.org/10.1158/1078-0432.c.7429474","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.7429474","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/1078-0432.c.7429474.v1","doi":"https://doi.org/10.1158/1078-0432.c.7429474.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.7429474.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.c.7429474","doi":"https://doi.org/10.1158/1078-0432.c.7429474","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.c.7429474","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4393259648","https://openalex.org/W4388048444","https://openalex.org/W4402173775","https://openalex.org/W4402173144","https://openalex.org/W4402173532","https://openalex.org/W4404119989","https://openalex.org/W4402173662","https://openalex.org/W4406863602","https://openalex.org/W4308385281","https://openalex.org/W4388082620"],"abstract_inverted_index":{"AbstractPurpose:":[0],"TILT-123":[1,42,171,209,230],"(igrelimogene":[2],"litadenorepvec)":[3],"is":[4],"an":[5],"oncolytic":[6],"adenovirus":[7],"armed":[8],"with":[9,86,133,198,206],"TNFa":[10],"and":[11,18,24,54,70,78,102,121,152,157,168,176,179,187,212,220,242,249],"IL2,":[12],"designed":[13,36],"to":[14,37,48,214],"induce":[15],"T-cell":[16],"infiltration":[17],"cytotoxicity":[19],"in":[20,43,165,174,183,192,196,202,218,223],"solid":[21,45],"tumors.":[22],"Patients":[23,51],"Methods:":[25],"TUNIMO":[26],"(NCT04695327)":[27],"was":[28,60,146,172,181,210],"a":[29,87],"single-arm,":[30],"multicenter":[31],"phase":[32],"I":[33],"dose-escalation":[34],"trial":[35],"assess":[38],"the":[39],"safety":[40,61],"of":[41,90,149,194,229,235],"advanced":[44],"cancers":[46,104],"refractory":[47],"standard":[49],"therapy.":[50],"received":[52],"intravenous":[53,186],"intratumoral":[55,188],"TILT-123.":[56],"The":[57,111,140],"primary":[58],"endpoint":[59],"by":[62,144,154,247],"adverse":[63],"events":[64],"(AE),":[65],"laboratory":[66],"values,":[67],"vital":[68],"signs,":[69],"electrocardiograms.":[71],"Secondary":[72],"endpoints":[73],"included":[74,97,116],"tumor":[75],"response,":[76],"pharmacokinetics,":[77],"predictive":[79],"biomarkers.":[80],"Results:":[81],"Twenty":[82],"patients":[83,125],"were":[84,109,126],"enrolled,":[85],"median":[88],"age":[89],"58":[91],"years.":[92],"Most":[93],"prevalent":[94],"cancer":[95],"types":[96],"sarcomas":[98],"(35%),":[99],"melanomas":[100],"(15%)":[101],"ovarian":[103],"(15%).":[105],"No":[106],"dose-limiting":[107],"toxicities":[108],"observed.":[110],"most":[112],"frequent":[113],"treatment-related":[114],"AEs":[115],"fever":[117],"(16.7%),":[118],"chills":[119],"(13.0%),":[120],"fatigue":[122],"(9.3%).":[123],"Ten":[124],"evaluable":[127,150,159],"for":[128],"response":[129],"on":[130],"day":[131],"78":[132],"RECIST":[134,155],"1.1,":[135],"iRECIST":[136],"or":[137],"PET-based":[138],"evaluation.":[139],"disease":[141],"control":[142],"rate":[143],"PET":[145],"6/10":[147],"(60%":[148],"patients)":[151],"2/10":[153],"1.1":[156],"iRECIST(20%of":[158],"patients).":[160],"Tumor":[161],"size":[162],"reductions":[163],"occurred":[164],"both":[166],"injected":[167,175],"non-injected":[169,177],"lesions.":[170],"detected":[173],"tumors,":[178,203],"virus":[180],"observed":[182],"blood":[184],"after":[185],"injections.":[189],"Treatment":[190],"resulted":[191],"reduction":[193],"lymphocytes":[195],"blood,":[197],"concurrent":[199],"lymphocyte":[200],"increases":[201],"findings":[204],"compatible":[205],"trafficking.":[207],"Conclusions:":[208],"safe":[211],"able":[213],"produce":[215],"antitumor":[216],"effects":[217],"local":[219],"distant":[221],"lesions":[222],"heavily":[224],"pre-treated":[225],"patients.":[226],"Good":[227],"tolerability":[228],"facilitates":[231],"combination":[232],"studies,":[233],"several":[234],"which":[236],"are":[237],"ongoing":[238],"(NCT04217473,":[239],"NCT05271318,":[240],"NCT05222932,":[241],"NCT06125197).":[243],"See":[244],"related":[245],"commentary":[246],"Silva-Pilipich":[248],"Smerdou,":[250],"p.":[251],"3649":[252]},"counts_by_year":[],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2024-09-04T00:00:00"}